Fidelity SPDR Advertisement
Home > Boards > Free Zone > Big Board Trading - Technical > *SCALPSWINGSTRADDLE* ($$$)

Pharmacyclics pullback a buying opportunity, says Credit Suisse

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
madrose1 Member Profile
Member Level 
Followed By 296
Posts 47,229
Boards Moderated 10
Alias Born 04/07/01
160x600 placeholder
U.s. Gdp Expands At 3.5% Rate
U.S. GDP advanced at a seasonally adjusted annual rate of 3.5% in 3Q, a sign of sustained growth fueled by government spending and a narrower trade deficit despite mounting concerns about the health of overseas economies.
More Top Equities Stories Of The Day
European Markets Show Signs of Stress--2nd Update
ADR Shares End Mixed; Sanofi, Banco Bilbao Vizcaya Argentaria Shares Fall
Shire Files 8K - Other Events
Apple CEO Says He's 'Proud to Be Gay'
Stoxx 600 Flirts With Three-week High
U.S. Stocks, Bonds Dip on Fed Outlook
FTSE 100 Ends Higher After Roller-coaster Day
European Stocks Climb For Third Straight Day
madrose1 Member Level  Monday, 03/25/13 08:37:55 AM
Re: None
Post # of 648410 
Pharmacyclics pullback a buying opportunity, says Credit Suisse
Credit Suisse would use the pullback in Pharmacyclics as a buying opportunity given the multi-billion dollar potential of ibrutinib. Shares are Outperform rated with a $90 price target

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist